Stockreport

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights [Yahoo! Finance]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF Positive data announced from Phase 1/2 trial Orphan Drug Designation granted by European Union Breakthrough Therapy Designation granted by U.S. Food and Drug Admini [Read more]